FORE Biotherapeutics

Philadelphia, Pennsylvania, United States

Cancer Precision Medicine Therapeutics Drug Development

FORE Biotherapeutics is a precision oncology company dedicated to developing innovative treatments that provide a better outcome for cancer patients. Its lead asset plixorafenib is a Class 1/V600 and 2 BRAF inhibitor with demonstrated clinical safety and early efficacy signals in the previous Phase 1/2a clinical trial. Leveraging a proprietary functional genomics platform that can screen a wide range of known mutations for cancer-driving genes, the FORE R&D team is optimizing drug development by identifying existing compounds with known clinical profiles and a clear path through clinical development to advance new medicines for patients without adequate treatment options.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out FORE Biotherapeutics on @MedStartr Today #AdvancedSolidTumors #CancerOncology #Cancer #PrecisionMedicine #Therapeutics #DrugDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/SmN4CfjY6ww

Get Involved in FORE Biotherapeutics

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: fore.bio/

Disease Areas

Advanced Solid Tumors Cancer & Oncology

Technologies

Precision Medicine TechOncologySmall Molecule DrugsTargeted Therapeutics

🌐Website

What do you think of FORE Biotherapeutics?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.